# Novartis Pharma Schweizerhalle Ag, Pratteln, Switzerland – FDA Inspections

Source: https://www.keypedia.com/companies/novartis-pharma-schweizerhalle-ag/98c70c71-2e4d-4ca3-9db3-d7582815b731

> Inspection records and compliance data for Novartis Pharma Schweizerhalle Ag in Pratteln. 8 FDA inspections on record, last inspected March 27, 2025.

---

## Details

- Name: Novartis Pharma Schweizerhalle Ag
- FEI Number: 3002865753
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: Rothausstrasse 61
- City: Pratteln
- Country Name: Switzerland
- Address: Rothausstrasse 61, Pratteln, Switzerland
- Country: Switzerland

## Related Documents

- FDA Inspection 1289844 - Novartis Pharma Schweizerhalle Ag - 2025-03-27 — source: FDA, date: March 27, 2025
- FDA Inspection 1289844 - Novartis Pharma Schweizerhalle Ag - 2025-03-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 27, 2025
- FDA Inspection 1180967 - Novartis Pharma Schweizerhalle Ag - 2022-08-25 — classification: No Action Indicated (NAI), source: FDA, date: August 25, 2022
- FDA Inspection 1099107 - Novartis Pharma Schweizerhalle Ag - 2019-07-05 — source: FDA, date: July 5, 2019
- FDA Inspection 1018347 - Novartis Pharma Schweizerhalle Ag - 2017-06-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 23, 2017
- [FDA Inspection 938183 - Novartis Pharma Schweizerhalle Ag - 2015-07-14](https://www.keypedia.com/records/fda_inspections/novartis-pharma-schweizerhalle-ag/32ece39a-6d27-4f5e-9dd8-69bdc335039a) — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2015
- FDA Inspection 810431 - Novartis Pharma Schweizerhalle Ag - 2012-09-25 — classification: No Action Indicated (NAI), source: FDA, date: September 25, 2012
- FDA Inspection 672696 - Novartis Pharma Schweizerhalle Ag - 2010-07-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 9, 2010
- FDA Inspection 618945 - Novartis Pharma Schweizerhalle Ag - 2009-09-10 — classification: No Action Indicated (NAI), source: FDA, date: September 10, 2009

## Related Companies

- [Vifor (International) Inc.](https://www.keypedia.com/companies/vifor-international-inc/dc2994bb-3747-44d2-98c0-c94f1091459d)
- [HAS Healthcare Advanced Synthesis S.A.](https://www.keypedia.com/companies/has-healthcare-advanced-synthesis-sa/e7d0363e-940e-4940-9b7f-dcf22a536160)
- [HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.](https://www.keypedia.com/companies/hebei-changshan-biochemical-pharmaceutical-co-ltd/99f2986f-9dfe-4e0b-ab50-ac8d60457f76)
- [Eisai Pharmaceuticals India Pvt. Ltd.](https://www.keypedia.com/companies/eisai-pharmaceuticals-india-pvt-ltd/3622baa1-510c-408a-b6cf-4bf87fa4b4ca)
- [Kalintis Healthcare Private Ltd.](https://www.keypedia.com/companies/kalintis-healthcare-private-ltd/3b2db5df-8bc4-4222-998d-3bdfb5bd0487)
- [Savior Lifetec Corporation](https://www.keypedia.com/companies/savior-lifetec-corporation/d1c40efd-330b-4f97-a681-ac4c430cc42b)
- [LG Chem., Ltd.](https://www.keypedia.com/companies/lg-chem-ltd/c82fc233-da2e-4a2d-a401-bbf6aa4c232f)
- [Protalix Ltd.](https://www.keypedia.com/companies/protalix-ltd/03315ab5-c1f4-41af-ab04-56c4658d1eeb)
- [Curia Spain SAU](https://www.keypedia.com/companies/curia-spain-sau/a097eb87-d69b-4eee-81f1-0a54db9adea5)
- [Fresenius Kabi Deutschland GmbH](https://www.keypedia.com/companies/fresenius-kabi-deutschland-gmbh/84a1e729-a4ec-4670-b359-24649f022152)